Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin

Figure 1 Incidence of ascites or encephalopathy or gastrointestinal haemorrhage from the beginning of the first treatment according to the response to antiviral treatment (SVR: Sustained virological response in dotted line; non-SVR in full line; Log-Rank, P = 0. 44).